6533b859fe1ef96bd12b80da

RESEARCH PRODUCT

Cross‐sectional comparative study of pharmacokinetics and efficacy between sucrose‐formulated recombinant factor VIII (Kogenate ® ) and BAY 81‐8973 (Kovaltry ® ) in patients with severe or moderate haemophilia A in prophylaxis

María Remedios MarquésJosé Luis PovedaSantiago BonanadAna Rosa CidSaturnino HayaJuan Eduardo Megías-vericatFelipe QuerolPau BoschEmilio Monte-boquetSofía Pérez-alenda

subject

Drug compoundingmedicine.medical_specialtyCross-sectional studybusiness.industryTreatment outcomeHematologyGeneral MedicineModerate haemophilia ARecombinant factor viiiPharmacokineticsInternal medicinemedicineIn patientYoung adultbusinessGenetics (clinical)https://doi.org/10.1111/hae.13733